{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:13:40Z","timestamp":1781050420325,"version":"3.54.1"},"reference-count":27,"publisher":"SLACK, Inc.","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Refract Surg"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To analyze the cost-effectiveness of the Light Adjustable Lens (LAL; RxSight) in comparison to a monofocal intraocular lens (IOL) for individuals undergoing cataract surgery in both eyes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A cost-effectiveness analysis was performed using a Markov model that simulated the patient outcomes and costs associated with undergoing cataract surgery with the LAL or monofocal IOL. Cost-effectiveness was determined using the incremental cost-effectiveness ratio (ICER), a measure that quantifies the incremental cost in dollars per quality-adjusted life year (QALY) gained. Treatments with the ICER below the willingness-to-pay threshold (WTP) of $50,000\/QALY were considered cost-effective. The model was also evaluated for the impact of uncertainties in parameters using one-way sensitivity and probabilistic sensitivity analyses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The cost-effectiveness analysis showed that the LAL is cost-effective compared to monofocal IOLs in patients undergoing cataract surgery, with ICERs of $9,792\/QALY (health care perspective) and $10,072\/QALY (societal perspective) both significantly below the WTP. The model was most sensitive to patient age, market cost of the LAL, and proportion of patients with residual astigmatism following cataract surgery. The probabilistic sensitivity analysis showed that cataract surgeries in patients starting at age 65 years were cost-effective in 94% of the simulations at a WTP of $50,000\/QALY.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>From both health care and societal perspectives, the study shows cataract surgeries performed with the LAL are cost-effective when compared to those performed with a monofocal IOL. More studies are needed to compare the LAL to other premium lenses that also provide patients with excellent visual outcomes at a higher cost.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                [\n                <jats:italic>J Refract Surg<\/jats:italic>\n                . 2023;39(11):777\u2013782.]\n              <\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/1081597x-20231016-01","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T12:22:41Z","timestamp":1699446161000},"page":"777-782","source":"Crossref","is-referenced-by-count":3,"title":["Cost-Effectiveness Analysis of Light Adjustable Lens Compared to Monofocal Intraocular Lens in Cataract Surgery"],"prefix":"10.3928","volume":"39","author":[{"given":"Taiki W.","family":"Nishihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Q.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhiannon D.","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_3_2_2","unstructured":"U.S. Food and Drug Administration. RxSight P160055: FDA Summary of Safety and Effectiveness Data. 2017."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2019.07.08"},{"key":"e_1_3_3_4_2","first-page":"29","article-title":"Light-adjustable lens: customizing correction for multifocality and higher-order aberrations","volume":"104","author":"Sandstedt CA","year":"2006","unstructured":"Sandstedt CA, Chang SH, Grubbs RH, Schwartz DM. Light-adjustable lens: customizing correction for multifocality and higher-order aberrations. Trans Am Ophthalmol Soc. 2006;104:29\u201339. PMID:17471323","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_3_5_2","first-page":"67","article-title":"Light-adjustable lens: development of in vitro nomograms","volume":"102","author":"Schwartz DM","year":"2004","unstructured":"Schwartz DM, Sandstedt CA, Chang SH, Kornfield JA, Grubbs RH. Light-adjustable lens: development of in vitro nomograms. Trans Am Ophthalmol Soc. 2004;102:67\u201372. PMID:15747746","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_3_6_2","first-page":"417","article-title":"Light-adjustable lens","volume":"101","author":"Schwartz DM","year":"2003","unstructured":"Schwartz DM. Light-adjustable lens. Trans Am Ophthalmol Soc. 2003;101:417\u2013436. PMID:14971588","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.03.019"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S370420"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.14.1637"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.5322"},{"key":"e_1_3_3_11_2","unstructured":"Social Security Actuarial Life Table. 2022. Accessed July 23 2022. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.151829"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_3_14_2","unstructured":"Haffey B. Study identifies clear positive economic impact of the RxSight Light Adjustable Lens\u00ae (LAL\u00ae) on practice revenues margins and outcomes. Published online June 22 2021. https:\/\/www.linkedin.com\/pulse\/study-identifies-clear-positive-economic-impact-rxsight-bernie-haffey-4f"},{"key":"e_1_3_3_15_2","unstructured":"Centers for Medicare & Medicaid Services. Medicare Physician Fee Schedule; 2022. https:\/\/Www.Cms.Gov\/Medicare\/Physician-Fee-Schedule\/Search?Y=0&T=4&HT=0&CT=3&H1=66984&M=5"},{"key":"e_1_3_3_16_2","unstructured":"Rossheim J. Does Medicare cover cataract surgery? NerdWallet. Retrieved August 24 2022 from https:\/\/www.nerdwallet.com\/article\/insurance\/medicare\/does-medicare-cover-cataract-surgery"},{"key":"e_1_3_3_17_2","unstructured":"Cost of cataract eye surgery in California. https:\/\/cost.sidecar-health.com\/s\/cataract-eye-surgery-cost-in-california"},{"key":"e_1_3_3_18_2","volume-title":"Stat-Pearls","author":"Lodhi O","year":"2022","unstructured":"Lodhi O, Tripathy K. Anesthesia For Eye Surgery. In: Stat-Pearls. StatPearls Publishing; 2022."},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.11.005"},{"key":"e_1_3_3_20_2","unstructured":"Prednisolone ophthalmic prices coupons Copay & Patient Assistance. Drugs.com. Accessed October 16 2023. https:\/\/www.drugs.com\/price-guide\/prednisolone-ophthalmic"},{"key":"e_1_3_3_21_2","unstructured":"Moxifloxacin ophthalmic prices coupons Copay & Patient Assistance. Drugs.com. Accessed October 16 2023. https:\/\/www.drugs.com\/price-guide\/moxifloxacin-ophthalmic"},{"key":"e_1_3_3_22_2","unstructured":"Ketorolac ophthalmic prices coupons Copay & Patient Assistance. Drugs.com. Accessed October 16 2023. https:\/\/www.drugs.com\/price-guide\/ketorolac-ophthalmic"},{"key":"e_1_3_3_23_2","unstructured":"United States Department of Labor. Bureau of Labor Statistics. CPI Inflation Calculator. Accessed August 18 2022. https:\/\/www.bls.gov\/data\/inflation_calculator.htm"},{"issue":"8","key":"e_1_3_3_24_2","first-page":"567","article-title":"Opportunity costs of ambulatory medical care in the United States","volume":"21","author":"Ray KN","year":"2015","unstructured":"Ray KN, Chari AV, Engberg J, Bertolet M, Mehrotra A. Opportunity costs of ambulatory medical care in the United States. Am J Manag Care. 2015;21(8):567\u2013574. PMID:26295356","journal-title":"Am J Manag Care"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-4182(00)80077-0"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2008.09.027"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3928\/1081597X-20140429-01"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.09.026"}],"container-title":["Journal of Refractive Surgery"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T12:23:11Z","timestamp":1699446191000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/1081597X-20231016-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.3928\/1081597X-20231016-01"],"URL":"https:\/\/doi.org\/10.3928\/1081597x-20231016-01","relation":{},"ISSN":["1081-597X"],"issn-type":[{"value":"1081-597X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}